Skandinaviska Enskilda Banken (SEB)
ADPT icon

Skandinaviska Enskilda Banken (SEB)’s Adaptive Biotechnologies ADPT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,200
Closed -$192K – 785
2023
Q4 		$192K Sell
39,200
-16,900
-30% -$77.1K ﹤0.01% 838
2023
Q3 		$306K Sell
56,100
-11,400
-17% -$75.4K ﹤0.01% 804
2023
Q2 		$453K Buy
67,500
+14,100
+26% +$105K ﹤0.01% 801
2023
Q1 		$472K Buy
+53,400
New +$471K ﹤0.01% 781

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ADPT Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Adaptive Biotechnologies (ADPT) in Q1 2024, closing a stake of 39,200 shares — an estimated $192K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ADPT in Q1 2023 and held it in 4 quarters. The position peaked at $472K in Q1 2023. 190 funds tracked by Wall St. Rank hold ADPT as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Adaptive Biotechnologies position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 39,200 Adaptive Biotechnologies shares in Q1 2024, an estimated $192K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Adaptive Biotechnologies in Q1 2023 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Adaptive Biotechnologies position peaked at $472K in Q1 2023.
  • 190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.